Skip to main content
Article
Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
Cell Stem Cell
  • C. Benedikt Westphalen, Klinikum der Universität München
  • Yoshihiro Takemoto, Columbia University Irving Medical Center
  • Takayuki Tanaka, Columbia University Irving Medical Center
  • Marina Macchini, Columbia University Irving Medical Center
  • Zhengyu Jiang, Columbia University Irving Medical Center
  • Bernhard W. Renz, Klinikum der Universität München
  • Xiaowei Chen, Columbia University Irving Medical Center
  • Steffen Ormanns, Klinikum der Universität München
  • Karan Nagar, Columbia University Irving Medical Center
  • Yagnesh Tailor, Columbia University Irving Medical Center
  • Randal May, University of Oklahoma
  • Youngjin Cho, Columbia University Irving Medical Center
  • Samuel Asfaha, Columbia University Irving Medical Center
  • Daniel L. Worthley, Columbia University Irving Medical Center
  • Yoku Hayakawa, Columbia University Irving Medical Center
  • Aleksandra M. Urbanska, Columbia University Irving Medical Center
  • Michael Quante, Klinik und Poliklinik für Innere Medizin II, Technische Universität München
  • Maximilian Reichert, Klinik und Poliklinik für Innere Medizin II, Technische Universität München
  • Joshua Broyde, Columbia University Irving Medical Center
  • Prem S. Subramaniam, Columbia University Irving Medical Center
  • Helen Remotti, Columbia University Irving Medical Center
  • Gloria H. Su, Columbia University Irving Medical Center
  • Anil K. Rustgi, Penn Medicine
  • Richard A. Friedman, Columbia University Irving Medical Center
  • Barry Honig, Columbia University Irving Medical Center
  • Andrea Califano, Columbia University Irving Medical Center
  • Courtney W. Houchen, University of Oklahoma
  • Kenneth P. Olive, Columbia University Irving Medical Center
  • Timothy C. Wang, Columbia University Irving Medical Center
Document Type
Article
Publication Date
4-7-2016
URL with Digital Object Identifier
10.1016/j.stem.2016.03.016
Abstract

The existence of adult pancreatic progenitor cells has been debated. While some favor the concept of facultative progenitors involved in homeostasis and repair, neither a location nor markers for such cells have been defined. Using genetic lineage tracing, we show that Doublecortin-like kinase-1 (Dclk1) labels a rare population of long-lived, quiescent pancreatic cells. In vitro, Dclk1+ cells proliferate readily and sustain pancreatic organoid growth. In vivo, Dclk1+ cells are necessary for pancreatic regeneration following injury and chronic inflammation. Accordingly, their loss has detrimental effects after cerulein-induced pancreatitis. Expression of mutant Kras in Dclk1+ cells does not affect their quiescence or longevity. However, experimental pancreatitis converts Kras mutant Dclk1+ cells into potent cancer-initiating cells. As a potential effector of Kras, Dclk1 contributes functionally to the pathogenesis of pancreatic cancer. Taken together, these observations indicate that Dclk1 marks quiescent pancreatic progenitors that are candidates for the origin of pancreatic cancer.

Citation Information
C. Benedikt Westphalen, Yoshihiro Takemoto, Takayuki Tanaka, Marina Macchini, et al.. "Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis" Cell Stem Cell Vol. 18 Iss. 4 (2016) p. 441 - 455
Available at: http://works.bepress.com/samuel-asfaha/12/